pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    CLD-101
    Anaplastic Astrocytoma$CLDI Calidi Biotherapeutics, Inc.
  • CLENPIQ
    CLENPIQ (SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID)
    no indication FERRING PHARMS INC
  • Preclinical
    CLG-001
    Mitochondrial Diseases Cellergy Therapeutics Ltd
  • CLINDAMYCIN AND BENZOYL PEROXIDE
← prev
page 70 of 231
next →
131
Pain89
Neurology1
CLINDAMYCIN AND BENZOYL PEROXIDE
no indication
GLENMARK SPECLT
  • CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC)
    CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC)
    no indication Aurobindo Pharma Ltd
  • CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1%
    CLINDAMYCIN PHOAPHATE TOPICAL SOLUTION USP, 1% (CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1%)
    no indication ENCUBE ETHICALS
  • CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
    CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (CLINDAMYCIN AND BENZOYL PEROXIDE GEL)
    no indication SUN PHARMA CANADA
  • CLINIMIX
    CLINIMIX (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DEXTROSE)
    no indication BAXTER HLTHCARE
  • CLINIMIX E
    CLINIMIX E (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE)
    no indication BAXTER HLTHCARE
  • CLINISOL
    CLINISOL (LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE)
    no indication BAXTER HLTHCARE
  • CLINOLIPID
    CLINOLIPID (OLIVE OIL AND SOYBEAN OIL)
    no indication BAXTER HLTHCARE CORP
  • Phase 2
    CLIO-8221
    Solid Tumor Callio Therapeutics Inc
  • Phase 1
    CLN-049
    Refractory Acute Myeloid Leukemia$CGEM Cullinan Therapeutics, Inc.
  • Phase 1
    CLN-978
    Systemic Lupus Erythematosus$CGEM Cullinan Therapeutics, Inc.
  • CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05%
    CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05% (CLOBETASOL PROPIONATE CREAM USP, 0.05%)
    no indication ENCUBE
  • CLOPIDOGREL
    CLOPIDOGREL
    no indication HETERO LABS LTD V
  • CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
    CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
    no indication TARO
  • CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%
    CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%
    no indication TP ANDA HOLDINGS
  • Phase 2
    CLR-121125
    Triple-Negative Breast Cancer (TNBC)$CLRB Cellectar Biosciences, Inc.
  • Preclinical
    CLRN1
    Usher Syndrome Akouos Inc
  • Preclinical
    CLS-014
    Pancreatic Cancer CLS Therapeutics
  • Phase 1
    CLY-124
    Sickle Cell Disease Cellarity Inc
  • Preclinical
    CM-109
    Gastric Cancer Excelmab Inc
  • Preclinical
    CM-110
    Small-Cell Lung Cancer Excelmab Inc
  • Phase 2
    CM-4612
    Attention Deficit Hyperactivity Disorder (ADHD) Curemark LLC
  • Phase 3
    CM-AT
    LUMINENZ-AT
    Autism Spectrum Disorder (ASD) Curemark LLC
  • Preclinical
    CMN-008
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Benecyte Inc
  • Phase 2
    CMND-100
    Alcohol Use Disorder (AUD)$CMND Clearmind Medicine Inc.
  • Phase 1
    CMS-121
    Alzheimer's Disease Virogenics Inc
  • Preclinical
    CMTS-1
    Type 2 Diabetes Celdara Medical LLC